Objective:To explore the clinical value of3.0T magnetic resonance whole-body imaging in the bone marrow infiltration of lymphoma combined with conventional MRI T2WI, STIR, T1-mDixon and WBDWI. Methods:62 patients with malignant lymphoma were collected. These patients were admitted to the Department of Hematology in Zhongda Hospital from December 2016 to June 2018. Using the Philips Ingenia Ⅱ 3.0T magnetic resonance scanner, the coils were used to perform the patient's coronal scan of conventional T2WI, STIR and T1-mDixon sequences, and transverse WBDWI scan. Four sequences for whole-body magnetic resonance imaging (T2WI, STIR, T1-mDixon, WBDWI) were combined in the following five different combinations:Combination 1, only using WBDWI technology; Combination 2, using T2WI combined with WBDWI technology; Combination 3, using STIR combined with WBDWI technology; Combination 4, using T1-mDixon combined with WBDWI technology; Combination 5, using T2WI, STIR and T1-mDixon combined with WBDWI technology. According to the gold standard for the diagnosis of lymphoma bone marrow infiltration, the evaluation scores compared with diagnostic results under different imaging protocols and histopathology results were used to evaluate the diagnostic efficacy of the above five examination combinations for bone marrow infiltration of malignant lymphoma(ML). The Mcnemar test was used. Results:The analyzing results of lymphoma bone marrow infiltration through different combinations of T1-mDixon, T2WI, STIR and WBDWI scanning showed:Of the 62 patients with suspected lymphoma bone marrow infiltration, 35 patients were diagnosed by bone marrow aspiration or biopsy pathology. The results of the McNemar tests between the two groups of the imaging combinations showed that the sensitivity and accuracy of Combination 4 and Combination 5 in the diagnosis of ML bone marrow infiltration weresignificantly different from the other combinations(P<0.000 1), but there was a statistically significant difference between Combination 4 and Combination 5 in the diagnosis specificity of ML bone marrow infiltration (P<0.05). Conclusion:For lymphoma patients with clinically suspected bone marrow infiltration, T2WI, STIR, T1-mDixon and WBDWI techniques may be used for whole body magnetic resonance examination. These imaging combinations could greatly improve the sensitivity and accuracy for detection and may have positive clinical effects on the diagnosis and treatment of lymphoma. |
[1] ABDULQADHR G,MOLIN D,ASTROM G,et al.Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients[J].Acta Radiologica,2011,52(2):173-180.
[2] GU J,CHAN T,ZHANG J,et al.Whole-body diffusion-weighted imaging:the added value to whole-body MRI at initial diagnosis of lymphoma[J].Am J Roentgenol,2011,197(3):W384-391.
[3] TSUJI K,KISHI S,TSUCHIDA T,et al.Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients:a comparision with FDG-PET/CT[J].J Magn Reson Imaging,2015,41(6):1601-1607.
[4] FOTI P V,FARINA R,CORONELLA M,et al.Diffusion-weighted magnetic resonance imaging for predicting and detecting the response of ocular melanoma to proton beam therapy:initial results[J].Radiol Med,2015,120(6):526-535.
[5] TOLEDANO-MASSIAH S,LUCIANI A,ITTI E,et al.Whole-body diffusion-weighted imaging in Hodgkin lymphoma and diffuse large B-cell lymphoma[J].Radiographics,2015,35(3):747-764.
[6] HAGTVEDT T,SEIERSTAD T,LUND K V,et al.Diffusion-weighted MRI compared to FDG PET/CT for assessment of early treatment response in lymphoma[J].Acta Radiol,2015,56(2):152-158.
[7] EVENS A M,KOSTAKOGLU L.The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease[J].Blood,2014,24(23):3356-3364.
[8] CHAWLA S C,FEDERMAN N,ZHANG D,et al.Estimated cumulative radiation dose from PET/CT in children with malignancies:a 5-year retrospective review[J].Pediatr Radiol,2010,40(5):681-686.
[9] 李岩,刘爱春.弥漫大B细胞淋巴瘤预后相关因素研究进展[J].东南大学学报(医学版),2017,36(4):666-670.
[10] LEONG K M,LAU P,RAMADAN S.Utilisation of MR spectroscopy and diffusion weighted imaging in predicting and monitoring of breast cancer response to chemotherapy[J].J Med Imaging Radiat Oncol,2015,59(3):268-277.
[11] SHORTT C P,GLEESON T G,BREEN K A,et al.Whole-body MRI versus PET in assessment of multiple myeloma disease activity[J].Am J Roentgenol,2009,192(4):980-986.
[12] SHAH L M,HANRAHAN C J.MRI of spinal bone marrow:part I,techniques and normal age-related appearances[J].Am J Roentgenol,2011,197(6):1298-1308.
[13] TAKAHARA T,IMAI Y,YAMASHITA T,et al.Diffusion weighted whole body imaging with background body signal suppression (DWIBS):technical improvement using free breathing,STIR and high resolution 3D display[J].Radiat Med,2004,22(4):275-282.
[14] ALBANO D,PATTI C,la GRUTTA L,et al.Comparison between whole-body MRI with diffusion-weighted imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas[J].Eur J Radiol,2016,85(2):313-318.
[15] MANENTI G,CICCIO C,SQUILLACI E,et al.Role of combined DWIBS/3D-CE-T1w whole-body MRI in tumor staging:comparison with PET-CT[J].Eur J Radiol,2012,81(8):1917-1925. |